Are you Dr. Hoang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 30 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-265-1700Fax+1 608-265-8133
Summary
- Dr. Tien Hoang, MD is an oncologist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin. He is affiliated with University Hospital and is an Assistant Professor at University of Wisconsin School of Medicine & Public Health.
Education & Training
SUNY Downstate Health Sciences UniversityFellowship, Hematology and Medical Oncology, 1998 - 2001
BronxCare Health SystemResidency, Internal Medicine, 1995 - 1998
Ho Chi Minh City Medicine and Pharmacy UniversityClass of 1987
Certifications & Licensure
WI State Medical License 2001 - 2023
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors Start of enrollment: 2003 Jul 01
- Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer Start of enrollment: 2008 Dec 01
- Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer Start of enrollment: 2009 Nov 01
Publications & Presentations
PubMed
- 37 citationsPhase 1 Trial of Bevacizumab With Concurrent Chemoradiation Therapy for Squamous Cell Carcinoma of the Head and Neck With Exploratory Functional Imaging of Tumor Hypox...Matthew J. Nyflot, Tim J. Kruser, Anne M. Traynor, Deepak Khuntia, David T. Yang
International Journal of Radiation Oncology, Biology, Physics. 2015-04-01 - 39 citationsIncreased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy.Donald M. Cannon, Heather M. Geye, Gregory K. Hartig, Anne M. Traynor, Tien Hoang
Head & Neck. 2014-08-01 - 30 citationsVorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II studyTien Hoang, Toby C. Campbell, Chong Zhang, KyungMann Kim, Jill M. Kolesar
Investigational New Drugs. 2014-02-01
